Ocumetics Technology Corp. announced the commencement of its project with Clinical Research Consultants Inc. of Cincinnati, Ohio. CRC and Ocumetics have entered into a consulting agreement whereby CRC will provide general regulatory, clinical, data management, statistical, quality and technical consulting services to Ocumetics to develop, support and implement the regulatory strategy for the Bionic LensTM.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.305 CAD | -1.61% | +3.39% | -10.29% |
1st Jan change | Capi. | |
---|---|---|
-10.29% | 26.77M | |
+3.20% | 7.63B | |
-6.99% | 4.53B | |
-4.77% | 2.98B | |
+8.82% | 2.19B | |
-30.15% | 1.07B | |
+10.56% | 1.03B | |
+4.09% | 905M | |
-47.58% | 829M | |
-19.25% | 719M |
- Stock Market
- Equities
- OTC Stock
- News Ocumetics Technology Corp.
- Ocumetics Announces Commencement of Regulatory Strategy Project with Clinical Research Consultants, Inc